Estados financieros detallados de ABVC BioPharma, Inc. (ABVC): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 100.0%, margen operativo 9.2%, margen neto 9.9%.
Al precio actual de $1.08, ABVC presenta beneficios negativos (P/E no significativo) y un ROE del -71.17%. La capitalización bursátil es de $28M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | $6956 | $701719 | $483045 | $355797 | $969783 | $152430 | $509589 | 0 |
| Coste de Ventas | $32 | 0 | $228890 | $20137 | $18716 | $5086 | $286415 | $302037 | $763 | 0 |
| Beneficio Bruto | -$32 | 0 | -$221934 | $681582 | $464329 | $350711 | $683368 | -$149607 | $508826 | 0 |
| I+D | $10.0M | $3.2M | $988721 | $1.0M | $549658 | $1.0M | $2.7M | $1.1M | $179272 | $121085 |
| Generales y Administrativos | $997203 | $967085 | $1.6M | $3.1M | $8.4M | $11.1M | $13.1M | $5.6M | $5.0M | $7.0M |
| Gastos Operativos | $11.0M | $4.1M | $2.6M | $4.1M | $9.0M | $12.1M | $15.8M | $6.6M | $5.2M | $7.2M |
| Beneficio Operativo | -$11.0M | -$4.1M | -$2.8M | -$3.5M | -$8.5M | -$11.7M | -$15.1M | -$6.8M | -$4.7M | -$7.2M |
| EBITDA | -$11.0M | -$4.1M | -$5.9M | -$3.5M | -$10.4M | -$11.0M | -$15.2M | -$6.3M | -$4.3M | -$7.4M |
| Gastos por Intereses | $10170 | $103460 | $462751 | $482014 | $405032 | $227210 | $293968 | $1.3M | $825899 | $415890 |
| Beneficio Antes de Impuestos | -$11.0M | -$4.2M | -$6.4M | -$4.0M | -$10.8M | -$11.2M | -$15.5M | -$8.0M | -$5.4M | -$8.4M |
| Impuestos | $836 | $830 | -$365097 | -$77041 | -$220352 | $825024 | $797778 | $256006 | -$110539 | $24154 |
| Beneficio Neto | -$11.0M | -$4.2M | -$5.6M | -$3.6M | -$9.8M | -$12.8M | -$16.4M | -$7.8M | -$4.9M | -$7.9M |
| BPA | $-10.21 | $-3.58 | $-4.69 | $-2.10 | $-5.00 | $-5.10 | $-5.20 | $-1.80 | $-0.42 | $-0.39 |
| BPA Diluido | $-10.80 | $-3.58 | $-4.69 | $-2.10 | $-5.00 | $-5.10 | $-5.20 | $-1.80 | $-0.42 | $-0.39 |
| Acciones en Circulación (Diluidas) | $1.2M | $1.2M | $1.2M | $1.7M | $2.0M | $2.5M | $3.2M | $4.3M | $11.7M | $23.3M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $18645 | $256925 | $40044 | $144295 | $5.0M | $5.8M | $1.4M | $716780 | $863815 | $681480 |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | $108147 | $75797 | $79312 | $64736 | $64354 |
| Cuentas por Cobrar | 0 | $2.5M | $14639 | $640526 | $999402 | $426091 | $1.4M | $759566 | $1.2M | $763388 |
| Inventario | 0 | $199708 | $1318 | -$476960 | 0 | $25975 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $18645 | $760973 | $96273 | $878238 | $6.2M | $7.7M | $3.0M | $1.7M | $2.2M | $2.5M |
| Inmovilizado Material | 0 | $570576 | $510066 | $1.0M | $2.3M | $2.0M | $1.7M | $1.4M | $1.2M | $14.7M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $18645 | $6.6M | $96273 | $6.9M | $14.8M | $13.7M | $10.9M | $7.8M | $7.5M | $21.1M |
| Cuentas por Pagar | 0 | 0 | $14639 | $23995 | $23044 | 0 | 0 | 0 | 0 | 0 |
| Deuda a Corto | 0 | $1.1M | $550000 | $4.0M | $2.7M | $1.9M | $2.6M | $2.4M | $3.0M | $1.9M |
| Pasivos Corrientes | $6.5M | $4.1M | $5.6M | $6.8M | $4.8M | $3.7M | $5.5M | $6.1M | $6.6M | $6.2M |
| Deuda a Largo | 0 | 0 | $250000 | 0 | $2.6M | 0 | 0 | 0 | 0 | $1.6M |
| Pasivos Totales | $6.5M | $4.1M | $5.8M | $7.1M | $8.9M | $4.8M | $6.3M | $6.5M | $6.8M | $7.8M |
| Reservas | -$11.5M | -$10.0M | -$19.9M | -$15.9M | -$25.6M | -$38.5M | -$54.9M | -$64.0M | -$68.9M | -$76.9M |
| Patrimonio Neto | -$6.5M | $1.7M | -$5.7M | -$150964 | $6.6M | $8.8M | $4.5M | $1.6M | $1.2M | $11.1M |
| Deuda Total | 0 | $1.2M | $800000 | $4.6M | $6.8M | $3.3M | $3.4M | $2.8M | $3.2M | $3.5M |
| Deuda Neta | -$18645 | $969197 | $759956 | $4.4M | $1.8M | -$2.6M | $1.9M | $2.0M | $2.3M | $2.7M |
| Capital Circulante | -$6.5M | -$3.3M | -$5.5M | -$5.9M | $1.3M | $4.0M | -$2.6M | -$4.4M | -$4.4M | -$3.7M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$4.5M | -$6.7M | -$4.1M | -$3.9M | -$10.6M | -$12.0M | -$16.3M | -$7.8M | -$5.3M | -$8.4M |
| Amortizaciones | 0 | $43996 | $43610 | $55086 | $37142 | $11993 | $23799 | $380390 | $200921 | $504834 |
| Compensación en Acciones | $1.3M | $155400 | $28800 | $22314 | $4.1M | $5.3M | $7.0M | $185933 | $2.8M | $4.1M |
| Cambio en Capital Circulante | -$262232 | $824808 | $892308 | $597667 | -$86434 | -$1.6M | $635565 | $309310 | -$408422 | -$615302 |
| Flujo de Caja Operativo | -$3.5M | -$1.7M | -$630195 | -$3.1M | -$4.6M | -$7.6M | -$7.4M | -$4.2M | -$1.8M | -$3.0M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 | 0 | -$17503 | -$119692 | -$21201 | $5 | 0 |
| Adquisiciones | 0 | -$7.8M | 0 | -$17801 | 0 | -$680916 | -$1.6M | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$7320 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$3.5M | -$1.7M | -$630195 | -$3.1M | -$4.6M | -$7.6M | -$7.5M | -$4.2M | -$1.8M | -$3.0M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +9988.0% | -31.2% | -26.3% | +172.6% | -84.3% | +234.3% | -100.0% | |||
| Crecimiento Beneficio Neto (anual) | +61.5% | -31.4% | +34.7% | -168.9% | -31.1% | -27.9% | +52.6% | +37.0% | -61.3% | |
| Crecimiento BPA (anual) | +64.9% | -31.0% | +55.2% | -138.1% | -2.0% | -2.0% | +65.4% | +76.7% | +7.1% | |
| Cambio en Acciones (anual) | +1.2% | +0.3% | +47.3% | +12.7% | +27.1% | +26.4% | +36.9% | +169.3% | +99.2% | |
| Crecimiento FCF (anual) | +51.5% | +62.6% | -397.4% | -45.6% | -66.9% | +1.3% | +44.0% | +57.0% | -65.1% | |
| Margen Bruto | -3190.5% | 97.1% | 96.1% | 98.6% | 70.5% | -98.1% | 99.9% | |||
| Margen Operativo | -40031.1% | -492.9% | -1760.9% | -3290.1% | -1558.5% | -4439.2% | -923.3% | |||
| Margen EBITDA | -85153.4% | -495.0% | -2147.2% | -3083.7% | -1567.0% | -4153.2% | -852.2% | |||
| Margen Neto | -80152.1% | -519.0% | -2027.0% | -3608.5% | -1693.5% | -5109.3% | -962.1% | |||
| Margen FCF | -9059.7% | -446.7% | -944.8% | -2140.3% | -775.2% | -2760.6% | -355.0% | |||
| Tasa Impositiva Efectiva | -0.0% | -0.0% | 5.7% | 1.9% | 2.0% | -7.4% | -5.1% | -3.2% | 2.1% | -0.3% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-2.97 | $-1.42 | $-0.53 | $-1.79 | $-2.31 | $-3.04 | $-2.37 | $-0.97 | $-0.15 | $-0.13 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $1.2M | $1.2M | $1.2M | $1.7M | $2.0M | $2.5M | $3.2M | $4.3M | $11.7M | $23.3M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -71.17% |
| Rentabilidad sobre capital invertido | -42.64% |
| Rentabilidad sobre activos | -37.55% |
| Margen bruto | 100.00% |
| Margen operativo | 918.55% |
| Margen neto | 992.85% |
Salud financiera
| Deuda / Patrimonio | 0.17 |
| Ratio corriente | 0.07 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -2.61 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -35.26 | -100.56 | -76.76 | -20.81 | -10.20 | -6.65 | -1.20 | -0.64 | -1.40 | -5.46 |
| P/VC | -64.67 | 256.71 | -74.39 | -506.54 | 15.24 | 9.60 | 4.44 | 3.24 | 5.62 | 4.46 |
| P/V | 0.00 | 0.00 | 61483.61 | 108.97 | 208.16 | 238.71 | 20.41 | 32.99 | 13.52 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | -3190.5% | 97.1% | 96.1% | 98.6% | 70.5% | -98.1% | 99.9% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | -40031.1% | -492.9% | -1760.9% | -3290.1% | -1558.5% | -4439.2% | -923.3% | 0.0% |
| Margen Neto | 0.0% | 0.0% | -80152.1% | -519.0% | -2027.0% | -3608.5% | -1693.5% | -5109.3% | -962.1% | 0.0% |
Empresas relacionadas: ATNM · FGEN · GRCE · JUNS · LTRN · LVTX · PDSB
Explorar sector: Healthcare · Biotechnology
Más secciones de ABVC: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones